Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older who have been diagnosed with advanced Parkinson's disease and are able to give their voluntary consent to participate.
- People whose treating doctor has already decided, as part of their regular clinical care, to start them on a commercially available continuous under-the-skin infusion medication called Foslevodopa/Foscarbidopa, with that decision made before and separately from any involvement in this study.
Who may not be able to join:
- People who are currently taking part in another interventional research study (studies that involve a treatment or procedure being tested) at the same time as receiving the Foslevodopa/Foscarbidopa infusion.
- People whose treating doctor has assessed them for the Foslevodopa/Foscarbidopa infusion at a location outside of a hospital setting.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: ABBVIE INC., AbbVie
Phone: 844-663-3742
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change From Baseline in OFF Time (hours) as measured by modified Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) IV
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.